🇺🇸 FDA
Patent

US 11608489

Compositions and methods for performing magnetibuoyant separations

granted A61KA61K35/28

Quick answer

US patent 11608489 (Compositions and methods for performing magnetibuoyant separations) held by BioLegend, Inc. expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioLegend, Inc.
Grant date
Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/28